腹部肥胖和代谢综合征
Jean-Pierre Després1, Isabelle Lemieux
1Québec Heart Institute, Hôpital Laval Research Centre, 2725 chemin Sainte-Foy, Pavilion Marguerite-D'Youville, 4th Floor, Quebec City, QC G1V 4G5, Canada. jean-pierre.despres@crhl.ulaval.ca
Nature
|December 15, 2006
概括
代谢综合征将腹部肥胖,脂质疾病和炎症与心血管疾病风险增加联系在一起. 然而,作为一个概念的价值仍在争论中,强调需要更好的风险评估工具.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 代谢综合征的特点是包括腹部肥胖,脂质不良,炎症和胰岛素抵抗在内的疾病集群.
- 这些情况共同增加患心血管疾病 (CVD) 和2型糖尿病的风险.
- 虽然存在诊断标准,但代谢综合征作为一个独特的实体的科学有效性和临床实用性仍然是持续辩论的主题.
研究的目的:
- 批判性地评估代谢综合征的科学概念.
- 评估其在预测全球心血管疾病风险方面的作用.
- 强调腹部肥胖作为临床标志物的重要性以及需要改进风险分层工具.
主要方法:
- 对代谢综合征的现有文献和诊断标准的审查.
- 对代谢综合征对心血管疾病风险的预测价值的分析.
- 评估腹部肥胖和功能障碍脂肪组织在代谢健康中的作用.
主要成果:
- 代谢综合征与多种心血管风险因素有关,但不能独立预测全球心血管疾病风险.
- 腹部肥胖是一个关键组成部分,是功能障碍脂肪组织的关键指标,对临床诊断至关重要.
- 目前的风险评估模型可能不足以准确量化糖尿病和心血管疾病风险的组合.
结论:
- 代谢综合征作为一个独立的诊断实体的临床实用性是有争议的.
- 腹部肥胖是一种关键的临床症状,反映了潜在的代谢功能障碍.
- 为了准确评估糖尿病和心血管疾病的全球风险,需要改进的算法.
相关概念视频
01:24Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
01:29Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
01:24Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
01:26Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57